Patents by Inventor Joseph Moriarty

Joseph Moriarty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240275083
    Abstract: Electrical connectors and assemblies may include a housing and a contact member therein. The contact member includes electrical contacts. A contact barrier is connected to the housing and movable between a closed state and an open state. In the open state, the contact member is exposed and, in the closed state, the contact member is protected by the contact barrier. The contact barrier is biased into the closed state. Electrical connectors and assemblies may include a housing with a core assembly having at least one electrical contact. A rotatable coupling member is rotatably attached to an end of the housing and includes a coupling housing, at least one latching element coupled to an inner surface of the coupling housing, and at least one center biasing element configured to bias and self-center the rotatable coupling member relative to the housing into a ready-to-connect orientation.
    Type: Application
    Filed: February 9, 2023
    Publication date: August 15, 2024
    Inventors: Ronald I. Frank, James R. Meszaros, George L. Goulart, Braden J. Ishaug, Robert G. Hennemuth, III, Michael D. Smith, Michael A. Yashin, Gordon J. Udall, Daniel R. McNevin, James Joseph Moriarty
  • Publication number: 20240227366
    Abstract: Optical interlayers, laminated composites and improved methods for manufacturing the optical interlayers and laminated composites are provided. An optical interlayer film comprises at least one surface having an embossed surface pattern having at least two channels extending in at least two non-parallel directions. The channels have a depth of greater than about 20 ?m. The surface pattern allows for the removal of air between the interlayer and the outer laminate sheets, thereby establishing the requisite seal therebetween while minimizing premature edge sealing. The laminated composites are particularly useful for safety glazing in a variety of applications, such as automobiles, airplanes, trains, or other modes of transportation, display devices, windows in homes and other buildings, building facades, cabinets, and/or weight bearing architectural structures such as stairs and floors.
    Type: Application
    Filed: October 9, 2023
    Publication date: July 11, 2024
    Inventors: Dave Collette, Joseph Moriarty
  • Publication number: 20240131823
    Abstract: Optical interlayers, laminated composites and improved methods for manufacturing the optical interlayers and laminated composites are provided. An optical interlayer film comprises at least one surface having an embossed surface pattern having at least two channels extending in at least two non-parallel directions. The channels have a depth of greater than about 20 ?m. The surface pattern allows for the removal of air between the interlayer and the outer laminate sheets, thereby establishing the requisite seal therebetween while minimizing premature edge sealing. The laminated composites are particularly useful for safety glazing in a variety of applications, such as automobiles, airplanes, trains, or other modes of transportation, display devices, windows in homes and other buildings, building facades, cabinets, and/or weight bearing architectural structures such as stairs and floors.
    Type: Application
    Filed: October 8, 2023
    Publication date: April 25, 2024
    Inventors: Dave Collette, Joseph Moriarty
  • Patent number: 9675445
    Abstract: An intraocular lens (31) which may be used as a posterior lens in a lens train including a converging anterior lens (20) and diverging posterior lens (31) in which the optical/focal axes of the two lenses are not coincident such that the focal point (9) of the lens train is offset from the focal axis of the anterior lens. Light rays (50) incident upon the anterior lens parallel to its focal axis may thus be directed (51) to parts of the retina offset from the fovea where the macula may not have degenerated.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: June 13, 2017
    Assignee: SEE AGAIN EUROPE LIMITED
    Inventor: Brendan Joseph Moriarty
  • Publication number: 20160106535
    Abstract: An intraocular lens (31) which may be used as a posterior lens in a lens train including a converging anterior lens (20) and diverging posterior lens (31) in which the optical/focal axes of the two lenses are not coincident such that the focal point (9) of the lens train is offset from the focal axis of the anterior lens. Light rays (50) incident upon the anterior lens parallel to its focal axis may thus be directed (51) to parts of the retina offset from the fovea where the macula may not have degenerated.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Inventor: Brendan Joseph Moriarty
  • Publication number: 20140223981
    Abstract: Described herein are fertilizers for enhancing the carbon sequestration properties of soil. The fertilizers described herein include algae comprising algaenan. In one aspect, the fertilizer includes (a) one or more organic nitrogen sources, (b) one or more synthetic nitrogen sources, and (c) algae comprising algaenan. The fertilizers and fertilizer compositions release nitrogen at a predictable rate over time, which can enhance growth of plants that are fertile with the composition described herein.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 14, 2014
    Applicants: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
    Inventors: Patrick G. Hatcher, John Joseph Moriarty
  • Patent number: 7479495
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Grant
    Filed: June 2, 2005
    Date of Patent: January 20, 2009
    Assignees: Pharmacopeia, Inc., Bristol-Myers Squibb Company
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Patent number: 7329675
    Abstract: This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; and N-oxides thereof, and pharmaceutically acceptable salts of the compounds of formula (I) and N-oxides thereof, Such compounds inhibit the production or physiological effects of TNF and inhibit cyclic AMP phosphodiesterase. The invention is also directed to pharmnaceutical compositions comprising compoundS of formula (I), their phatmaceUtical use and methods for their preparation.
    Type: Grant
    Filed: September 1, 2004
    Date of Patent: February 12, 2008
    Assignee: Aventis Pharma Limited
    Inventors: Paul Joseph Cox, Shelley Bower, David John Aldous, Peter Charles Astles, Daniel Gerard McGarry, Christopher Hulme, John Robinson Regan, Fu-Chih Huang, Stevan Wakefield Djuric, Kevin Joseph Moriarty, Rose Mappilakunnel Mathew, Gregory Bernard Poli
  • Patent number: 7179819
    Abstract: Compounds that selectively inhibit the binding of ligands to ?4?1 integrin (VLA-4) and methods for their preparation are disclosed. In one embodiment, compounds of the invention are represented by Formula I: As selective inhibitors of VLA-4 mediated cell adhesion, compounds of the present invention are useful in the treatment of conditions associated with such adhesion, including, but not limited to, such conditions as inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting VLA-4 mediated cell adhesion and methods of treating conditions associated with LA-4 mediated cell adhesion.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: February 20, 2007
    Assignees: Daiichi Pharmaceutical Co., Ltd., Pharmacopeia Drug Discovery, Inc.
    Inventors: John J. Baldwin, Edward McDonald, Kevin Joseph Moriarty, Christopher Ronald Sarko, Nobuo Machinaga, Atsushi Nakayama, Jun Chiba, Iimura Shin, Yoshiyuki Yoneda
  • Publication number: 20050184465
    Abstract: Finishing a seal assembly as a unit is proposed, which prevents alignment of the end gaps of the annular body and the annular ring of the seal assembly, provides the ability to manufacture the seal assembly to very low tolerances, and establishes virtually perfect parallelism between the upper and lower surfaces of the seal assembly. A finishing process is characterized by lapping a seal assembly as an assembled unit with a lapper using gritted oil as a polishing medium.
    Type: Application
    Filed: April 18, 2005
    Publication date: August 25, 2005
    Inventors: Maurice Moriarty, Matthew Hartford, Joseph Moriarty
  • Patent number: 6906067
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: June 14, 2005
    Assignees: Bristol-Myers Squibb Company, Pharmaceopeia, Inc.
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Patent number: 6884161
    Abstract: A rotary crop processing unit for a combine is shown having a generally cylindrical rotor within a frusto-conical housing. The rotor is arranged in the housing with a generally constant gap between the rotor and the bottom of the housing along the housing length and with an increasing gap between the rotor and the top of the housing in the crop flow direction.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: April 26, 2005
    Assignee: Deere & Company
    Inventor: Kevin Joseph Moriarty
  • Publication number: 20040229858
    Abstract: Compounds that selectively inhibit the binding of ligands to &agr;4&bgr;1 integrin (VLA-4) and methods for their preparation are disclosed.
    Type: Application
    Filed: February 26, 2004
    Publication date: November 18, 2004
    Applicants: Daiichi Pharmaceutical Co., LTD., Pharmacopeia Drug Discovery, Inc.
    Inventors: John J. Baldwin, Edward McDonald, Kevin Joseph Moriarty, Christopher Ronald Sarko, Nobuo Machinaga, Atsushi Nakayama, Jun Chiba, Shin Iimura, Yoshiyuki Yoneda
  • Patent number: 6800645
    Abstract: This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; R1 represents hydrogen or a straight- or branched-chain alkyl group of 1 to about 4 carbon atoms, optionally substituted by hydroxy or one or more halogen atoms, or when Z1 represents a direct bond R1 may also represent a lower alkenyl or lower alkynyl group, or a formyl group; R2 represents hydrogen, alkenyl, alkoxy, alkyl, alkylsulphinyl, alkylsulphonyl, alkylthio, aryl, arylalkyloxy, arylalkylsulphinyl, arylalkylsulphonyl, arylalkylthio, aryloxy, arylsulphinyl, arylsulphonyl, arylthio, cyano, cycloalkenyl, cycloalkenyloxy, cycloalkyl, cycloalkyloxy, heteroaryl, heteroarylalkyloxy, heteroaryloxy, hydroxy, —SO2NR4R5, —NR4SO2R5, —
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: October 5, 2004
    Assignee: Aventis Pharma Limited
    Inventors: Paul Joseph Cox, Shelley Bower, David John Aldous, Peter Charles Astles, Daniel Gerard McGarry, Christopher Hulme, John Robinson Regan, Fu-Chih Huang, Stevan Wakefield Djuric, Kevin Joseph Moriarty, Rose Mappilakunnel Mathew, Gregory Bernard Poli
  • Patent number: 6756378
    Abstract: Compounds that selectively inhibit the binding of ligands to &agr;4&bgr;1 integrin (VLA-4) and methods for their preparation are disclosed. In one embodiment, compounds of the invention are represented by Formula I: As selective inhibitors of VLA-4 mediated cell adhesion, compounds of the present invention are useful in the treatment of conditions associated with such adhesion, including, but not limited to, such conditions as inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are pharmaceutical compositions, methods of inhibiting VLA-4 mediated cell adhesion and methods of treating conditions associated with LA-4 mediated cell adhesion, which involve compounds of Formula I.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: June 29, 2004
    Assignees: Pharmacopeia Drug Discovery, Inc., Daiichi Pharmaceutical Co., Ltd.
    Inventors: John J. Baldwin, Edward McDonald, Kevin Joseph Moriarty, Christopher Ronald Sarko, Nobuo Machinaga, Atsushi Nakayama, Jun Chiba, Shin Iimura, Yoshiyuki Yoneda
  • Publication number: 20030078249
    Abstract: Compounds that selectively inhibit the binding of ligands to &agr;4&bgr;1 integrin (VLA-4) and methods for their preparation are disclosed.
    Type: Application
    Filed: December 28, 2001
    Publication date: April 24, 2003
    Applicant: Daiichi Pharmaceutical Co., LTD.
    Inventors: John J. Baldwin, Edward McDonald, Kevin Joseph Moriarty, Christopher Ronald Sarko, Nobuo Machinaga, Atsushi Nakayama, Jun Chiba, Shin Iimura, Yoshiyuki Yoneda
  • Publication number: 20020193155
    Abstract: A rotary crop processing unit for a combine is shown having a generally cylindrical rotor within a frusto-conical housing. The rotor is arranged in the housing with a generally constant gap between the rotor and the bottom of the housing along the housing length and with an increasing gap between the rotor and the top of the housing in the crop flow direction.
    Type: Application
    Filed: August 2, 2002
    Publication date: December 19, 2002
    Inventor: Kevin Joseph Moriarty
  • Patent number: 6468152
    Abstract: A rotary crop processing unit for a combine is having a generally cylindrical rotor within a frusto-conical housing. The rotor is arranged in the housing with a generally constant gap between the rotor and the bottom of the housing along the housing length and with an increasing gap between the rotor and the top of the housing in the crop flow direction.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: October 22, 2002
    Assignee: Deere & Company
    Inventor: Kevin Joseph Moriarty
  • Publication number: 20020137747
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 26, 2002
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20020121078
    Abstract: A rotary crop processing unit for a combine is shown having a generally cylindrical rotor within a frusto-conical housing. The rotor is arranged in the housing with a generally constant gap between the rotor and the bottom of the housing along the housing length and with an increasing gap between the rotor and the top of the housing in the crop flow direction.
    Type: Application
    Filed: March 2, 2001
    Publication date: September 5, 2002
    Applicant: Deere & Company, a Delaware corporation.
    Inventor: Kevin Joseph Moriarty